相关实验视频

Updated: Jun 30, 2026

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

辅助疗法的作用在切除的周围囊腺癌中:一个倾向匹配的病例控制研究

Anurita Srivastava¹, Phani Kumar Nekarakanti², Sudheer Kanchodu²

¹Department of Radiotherapy, Maulana Azad Medical College (MAMC), New Delhi, India.

Annals of hepato-biliary-pancreatic surgery

|April 11, 2024

概括

辅助化疗可能会改善切除非胰腺周围肺癌 (PACA) 患者的整体存活率. 需要进一步的前性研究来证实这些发现,以治疗周围癌症.

科学领域:

在瘤学瘤学.
手术瘤学手术瘤学
胃肠道瘤学胃肠道瘤学

背景情况:

关于在切除的周围肺癌 (PACA) 中辅助疗法的疗效存在相互矛盾的数据.
评估辅助治疗的生存益处对于优化患者的治疗结果至关重要.

研究的目的:

评估辅助化疗对切除非胰腺周围肺癌 (PACA) 患者的生存益处.

主要方法:

通过使用前性维护数据库 (2004-2019) 进行了一项与倾向性得分匹配的病例控制研究.
分析了接受治疗切除的非胰腺PACA患者,将接受辅助化疗的患者 (病例) 与单独观察到的患者 (对照) 进行比较.

主要成果:

在倾向性得分匹配后 (70例,70对照),化学疗法组的整体存活率 (OS) 呈现出非显著的改善趋势 (71 vs. 36个月,p=0.087).
无复发生存期 (RFS) 在各组之间没有显著差异 (53个月与40个月,p=0.797).
更糟糕的RFS的独立因素包括年轻的年龄,晚期的T阶段和围神经侵入;瘤复发预测了糟糕的生存状况.

结论:

辅助化疗可能为非胰腺PACA患者提供整体生存益处.
建议通过大型前性随机研究进行验证,以证实这些发现.

关键词:

辅助性化疗是一种辅助性化疗.阿姆普拉的父亲的外科手术手术手术

更多相关视频

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.